LMR Partners »

Amylyx Pharmaceuticals shares owned by LMR Partners

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by LMR Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $368k 25k 14.72

More positions owned by LMR Partners

Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr National Mun Etf Call Option (MUB)
Pdd Holdings Note10/0 (Principal)
On Semiconductor Corp Note5/0 (Principal)
Tripadvisor Put Option (TRIP)
Cytokinetics Note 4.000%11/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Advanced Micro Devices Call Option (AMD)
Dish Network Corporation Note 3.375% 8/1 (Principal)
BP Sponsored Adr (BP)
NVIDIA Corporation (NVDA)
United States Steel Corporation (X)
Carnival Corp Common Stock Put Option (CCL)

View all positions for LMR Partners

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Jupiter Asset Management
Marshall Wace
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft

View all funds holding Amylyx Pharmaceuticals